Max Robotics — Global Service Robot Directory + US Certification

About

Alessandro Gentilucci is a urological surgeon and researcher whose work centers on minimally invasive surgical techniques for urological cancers, with a particular focus on prostate and kidney cancer. His research has made meaningful contributions to understanding how surgical approach, operative precision, and technique selection influence both oncological and functional patient outcomes. Gentilucci has been especially prolific in comparative analyses of radical prostatectomy techniques, rigorously examining robotic-assisted versus laparoscopic approaches across multiple dimensions, including surgical margins, nerve-sparing efficacy, operative time, blood loss, and post-operative functional recovery. His prospective and real-life single-surgeon studies provide particularly valuable insights by controlling for operator variability — a methodological strength that lends credibility to his findings. His 2021 work on operative time and blood loss influencing surgical margins has garnered 12 citations, reflecting its practical relevance to surgical planning. In parallel, his 2022 critical review of nephron-sparing surgery for kidney cancer — his most cited work with 13 citations — synthesizes two decades of literature to identify key factors preserving renal function post-operatively. Collectively, Gentilucci's contributions offer clinicians evidence-based guidance on optimizing surgical decision-making, balancing oncological control with quality-of-life preservation for patients undergoing urological cancer surgery.